Apricus Biosciences Inc (NASDAQ:APRI)

Data as of Jan 28
 +0.11 / +9.02%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Apricus Biosciences, Inc. is a pharmaceutical company that has developed alternative, fast-acting, treatments which appeal to large patient populations that struggle with sexual performance. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.

Contact Information

Apricus Biosciences, Inc.
11975 El Camino Real
San Diego California 92130
P:(858) 222-8041
Investor Relations:



Individual stakeholders7.65%
Other institutional4.22%
Mutual fund holders3.88%

Top Executives

Richard W. PascoeChief Executive Officer & Director
Catherine BovenizerChief Accounting Officer & Vice President-Finance
Barbara TroupinChief Medical Officer
Brian T. DorseyChief Development Officer & Senior Vice President
Neil C. MortonVice President-Business Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.